Analystreport

AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $9.00 price target on the stock.

AVEO Pharmaceuticals, Inc.  (AVEO) 
Last aveo pharmaceuticals, inc. earnings: 3/16 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.aveooncology.com